A Phase 1，Open-label Study of BPI-421286 in Subjects With Advanced Solid Tumors
Clinical trial NCT05315180 · UNKNOWN
Trial details
- NCT number
- NCT05315180
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2023-07-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.